SPHK1 and prostate carcinoma: In addition, SphK1 enzymatic activity and expression are markedly increased in tumor samples from prostate cancer patients (as compared with normal counterparts) correlating with other markers such as PSA level, tumor grade as well as with the clinical outcome after prostatectomy (Malavaud and Cuvillier, submitted).